IRIS - Res&Arch Institutional Research Information System - Research & Archive

PUXEDDU, Efisio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.232
EU - Europa 3.685
AS - Asia 2.716
SA - Sud America 548
AF - Africa 42
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 2
Totale 11.234
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.158
SG - Singapore 1.193
UA - Ucraina 720
SE - Svezia 564
IE - Irlanda 522
BR - Brasile 479
IT - Italia 433
HK - Hong Kong 430
CN - Cina 384
RU - Federazione Russa 362
VN - Vietnam 356
FR - Francia 343
DE - Germania 251
KR - Corea 213
FI - Finlandia 194
GB - Regno Unito 102
BE - Belgio 32
MX - Messico 30
CA - Canada 29
CH - Svizzera 26
IN - India 24
AR - Argentina 23
AT - Austria 23
NL - Olanda 21
PL - Polonia 21
TR - Turchia 20
BD - Bangladesh 18
RO - Romania 13
IQ - Iraq 12
CO - Colombia 11
ES - Italia 11
CZ - Repubblica Ceca 10
PY - Paraguay 10
EC - Ecuador 9
GR - Grecia 9
ZA - Sudafrica 9
EU - Europa 8
ID - Indonesia 8
JP - Giappone 8
UZ - Uzbekistan 8
BG - Bulgaria 7
IL - Israele 7
LT - Lituania 6
LB - Libano 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
CL - Cile 4
DZ - Algeria 4
EG - Egitto 4
KE - Kenya 4
AL - Albania 3
AM - Armenia 3
AO - Angola 3
BO - Bolivia 3
HN - Honduras 3
MA - Marocco 3
MY - Malesia 3
PK - Pakistan 3
CI - Costa d'Avorio 2
DO - Repubblica Dominicana 2
EE - Estonia 2
ET - Etiopia 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LU - Lussemburgo 2
MD - Moldavia 2
NP - Nepal 2
PA - Panama 2
PE - Perù 2
QA - Qatar 2
TN - Tunisia 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
BB - Barbados 1
BF - Burkina Faso 1
BZ - Belize 1
CR - Costa Rica 1
CY - Cipro 1
DJ - Gibuti 1
GA - Gabon 1
GE - Georgia 1
GL - Groenlandia 1
GN - Guinea 1
GT - Guatemala 1
HU - Ungheria 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
MK - Macedonia 1
ML - Mali 1
MN - Mongolia 1
NG - Nigeria 1
NI - Nicaragua 1
OM - Oman 1
PH - Filippine 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
Totale 11.227
Salva come PNG Salva come JPEG
Città #
Singapore 741
Chandler 721
Dublin 522
Hong Kong 430
Jacksonville 402
San Mateo 285
Dong Ket 243
Boardman 235
Seoul 194
Santa Clara 190
Ashburn 152
Medford 151
Princeton 147
Altamura 126
Wilmington 122
Perugia 118
Moscow 105
Ann Arbor 104
Lawrence 97
Andover 94
Beijing 86
Piscataway 84
Munich 83
Los Angeles 58
Ho Chi Minh City 46
New York 39
Woodbridge 39
Saint Petersburg 38
Helsinki 35
São Paulo 34
Des Moines 33
Brussels 32
Hanoi 30
Turku 28
Redmond 27
Shanghai 25
Auburn Hills 23
Falls Church 23
Rome 23
Norwalk 19
Dallas 18
San Paolo di Civitate 17
Chicago 16
Council Bluffs 16
Atlanta 15
London 15
Denver 13
Phoenix 13
Bucharest 12
Columbus 12
Curitiba 12
Belo Horizonte 11
Brooklyn 11
Chennai 11
Guangzhou 11
Nuremberg 11
Toronto 11
Warsaw 11
Boston 10
Houston 10
Redwood City 10
Rio de Janeiro 10
The Dalles 10
Bologna 9
Brasília 9
Falkenstein 9
Lausanne 9
San Francisco 9
San Jose 9
Amsterdam 8
Fremont 8
Mexico City 8
Tokyo 8
Charlotte 7
Frankfurt am Main 7
Izmir 7
Johannesburg 7
Orem 7
Vienna 7
Den Haag 6
Guarulhos 6
Lappeenranta 6
Manchester 6
Ribeirão Preto 6
Stockholm 6
Baghdad 5
Buffalo 5
Edinburgh 5
Frankfurt Am Main 5
Limeira 5
Manaus 5
Montreal 5
Naples 5
Piracicaba 5
Recife 5
Salvador 5
San Diego 5
Sasso Marconi 5
São Bernardo do Campo 5
São José do Rio Preto 5
Totale 6.509
Salva come PNG Salva come JPEG
Nome #
Aspirato con ago sottile dei noduli tiroidei: striscio convenzionale vs preparato in strato sottile. 143
A useful ultrasound score to select thyroid nodules requiring fine needle aspiration in an iodine-deficient area. 140
Insights into the molecular function of the inactivating mutations of B-Raf involving the DFG motif 131
Analisi del proteoma di carcinomi papillari della tiroide positivi per la mutazione BRAFV600E 128
Genotyping of an Italian papillary thyroid carcinoma cohort revealed high prevalence of BRAF mutations, absence of RAS mutations and allowed the detection of a new mutation of BRAF oncoprotein (BRAF). 127
A usefull ultrasound score to select thyroid nodules requiring FNA in an iodine area 119
Analisi del meccanismo dominante inibitorio esercitato in cis dalle mutazioni inattivanti D594V e G596R sulla mutazione attivante di BRAF V600E 112
. Indoleamine 2,3-dioxygenase expression in papillary thyroid carcinoma : study of its correlation with tumor genetics and clinical behaviour 110
BRAF mutations in papillary thyroid carcinomas inhibit genes involved in iodine metabolism 110
Analysis of human MDM4 variants in papillary thyroid carcinomas reveals new potential markers of cancer properties. 108
Androgen Receptor Mutations in Prostate Cancer 108
Etiopatogenesi dei carcinomi della tiroide che originano dall’epitelio follicolare 106
BRAF(V600E) mutation and expression of proangiogenic molecular markers in papillary thyroid carcinomas. 106
L’ecografia intraoperatoria nella chirurgia delle recidive del cancro differenziato della tiroide. 105
Primitive thyroid lymphomas 104
Espressione di MKP-1 nei noduli iperplastici, adenomi e carcinomi papillari della tiroide. 102
Timing of breakfast does not influence therapeutic efficacy of liquid levothyroxine formulation 101
The role of BRAF V6ooE in regulating the expression of proangiogenic factors in papillary thyroid carcinomas : in vivo and in vitro analysis. 100
Search of ret/ptc rearrangement and braf and ras mutations in a umbrian papillary thyroid carcinoma cohort showed high prevalence of braf mutation and allowed to detect a new mutation of braf oncoprotein 99
Medicina molecolare in chirurgia della tiroide 99
Analisi della espressione degli oncogeni RET/PTC e del proto-oncogene RET in una coorte di carcinomi papillari della tiroide sporadici e correlazione con le caratteristiche clinico-patologiche delle neoplasie 99
Fine needle aspiration cytology of thyroid nodules: conventional smears vs thin layer technique 98
Identification of differentially expressed proteins in papillary thyroid carcinomas with V600E mutation of BRAF 96
Caratterizzazione biochimica e molecolare della nuova mutazione BRAFV599Ins recentemente individuata in un carcinoma papillare della tiroide 96
Activating PTPN11 mutations play a minor role in pediatric and adult solid tumors 95
Methylglyoxal Acts as a Tumor-Promoting Factor in Anaplastic Thyroid Cancer 95
Gemcitabine-loaded PEGylated unilamellar liposomes vs GEMZAR: biodistribution, pharmacokinetic features and in vivo antitumor activity. 93
The aryl hydrocarbon receptor is expressed in thyroid carcinoma and appears to mediate epithelial-mesenchymal-transition 93
Revisione della casistica dei pazienti affetti da oftalmopatia basedowiana seguiti presso il Dipartimento di Medicina Interna dell’Università degli Studi di Perugia negli anni 1990-2007 92
Correlation between B-RAFV600E mutation and clinico-pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literature. 92
Surgical treatment of intrathyroid metastases: preliminary results of a multicentric study 92
B-RAF activating mutations inhibit genes related to intrathyroidal iodine metabolism in papillary thyroid carcinoma 92
Alternative strategies for targeting mouse double minute 2 activity with small molecules: novel patents on the horizon? 92
Insights into the molecular function of the inactivating mutations of B-Raf involving the DFG motif. 91
Surgical treatment of sporadic medullary thyroid carcinoma: strategy and outcome. 90
I tumori della tiroide 90
BRAF(V599E) mutation is the leading genetic event in adult sporadic papillary thyroid carcinomas 89
L’analisi proteomica del carcinoma papillare della tiroide evidenzia modificazioni dello stato ossidoriduttivo e della struttura delle cellule tumorali 88
Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer 88
Long glucocorticoid-induced leucine zipper regulates human thyroid cancer cell proliferation 88
Molecular dynamic simulations of the catalytic domain of BRAF in response to activating and inactivating mutations 87
Severe spruelike enteropathy due to olmesartan 87
The Stone Guest: How Does pH Affect Binding Properties of PD-1/PD-L1 Inhibitors? 87
Anti-htert sirna-loaded nanoparticles block the growth of anaplastic thyroid cancer xenograft 84
Proteomic analysis of papillary thyroid carcinoma reveals demodulation of mechanisms regulating cell proliferation, susceptibility to oxidative stress and cellular aggregation 83
Braf mutation testing in fnac samples increases accuracy of thyroid cytology in a region of high braf mutation prevalence 83
Association between BRAF V600E mutation and recurrence of papillary thyroid cancer 83
Surgical treatment of primitive thyroid lymphoma 82
B-Raf(V600E) and thrombospondin-1 promote thyroid cancer progression. 82
8th edition of the AJCC/TNM staging system of thyroid cancer: what to expect (ITCO#2) 82
A combined approach for thyroid fine needle aspiration: liquid based cytology, cell block and immunohistochemical methods with the implementation of the Cellient™ automated cell block system 81
BRAF mutations and RET/PTC rearrangements in an italian thyroid tumor cohort 81
The 2009 American Thyroid Association Guidelines for management of thyroid nodules and differentiated thyroid cancer: progress on the road from consensus- to evidence-based practice. 81
Clinical implications of BRAF mutation in thyroid carcinoma 81
Recurrence of thyroid well differentiated cancer: ultrasonography-guided surgical treatment 81
Surgical treatment of medullary thyroid carcinoma (MTC) 81
Are Evidence-Based Guidelines Reflected in Clinical Practice? An Analysis of Prospectively Collected Data of the Italian Thyroid Cancer Observatory 81
Le sostituzioni aminoacidiche G596R e D594V hanno un effetto inibitorio dominante sulla funzione della mutazione V600E di BRAF 80
Sunitinib inhibits tumor vascularity and growth but does not affect Akt and ERK phosphorylation in xenograft tumors. 80
Immunohistochemical analisis of extracellular matrix metalloproteinase inducer (EMMPRIN/CD147) in papillary thyroid carcinoma (PYC): a marker of lymph node metastasis. 79
INDOLEAMINE 2,3-DIOXYGENASE 1 (IDO1) IS UPREGULATED IN THYROID CARCINOMA AND DRIVES THE DEVELOPMENT OF AN IMMUNOSUPPRESSANT TUMOR MICROENVIRONMENT. 79
Acromegaly is associated with increased cancer risk: a survey in Italy 79
Diagnostic-therapeutic pathways as instruments of clinical management: experience at the S. Maria Hospital in Terni 78
Aspetti di biologia molecolare degli ipertiroidismi 78
Liver alcoholic cirrhosis and spur-cell (acanthocytic) anaemia. A study of erythrocyte ghost composition and fluidity 77
Confronto tra citologia aspirativa con ago sottile e parametri eco-color-doppler nei noduli tiroidei 77
INSL4 as prognostic marker for proliferation and invasiveness in non-small-cell lung cancer 76
Conditional expression of RET/PTC induces a weak oncogenic drive in thyroid PCCL3 cells 75
La mutazione V599E dell’oncogene BRAF rappresenta l’alterazione genetica più frequente nei carcinomi papillari della tiroide sporadici dell’adulto 75
Characterization of novel non-clonal intrachromosomal rearrangements between the H4 and PTEN genes (H4/PTEN) in human thyroid cell lines and papillary thyroid cancer specimens 75
Signal transducer and activator of transcription 1 plays a pivotal role in RET/PTC3 oncogene-induced expression of indoleamine 2,3-dioxygenase 1 75
Conditional expression of RET/PTC3 in PCCL3 cells induces microsomal Prostaglandin E Synthase expression and Prostaglandin E2 biosynthesis through the activation of MEK-ERK pathway 74
Biochemical and molecular characterization of the novel BRAF(V599Ins) mutation detected in a classic papillary thyroid carcinoma. 74
Comparison between fine needle aspiration cytology and ultrasound features in thyroid nodules: an US score to select thyroid nodules requiring FNA. 73
Patogenesi del carcinoma della tiroide 72
Surgical treatment of differenziated thyroid carcinoma: a retrospective study 71
Isozyme-specific abnormalities of protein kinase C in thyroid cancer: evidence for epigenetic changes in PKC epsilon 70
Caratterizzazione di un riarrangiamento non clonale tra i geni H4 e PTEN (H4/PTEN) in cellule tiroidee umane e in campioni di carcinoma papillare della tiroide 69
Oncogeni e chirurgia della tiroide 69
Germline BRAF mutations in Noonan, LEOPARD and cardiofaciocutaneous syndromes: molecular diversity and associated phenotypic spectrum 69
Epigenetics of thyroid cancer and novel therapeutic targets. 69
Molecular dynamic simulation of the catalytic domain of BRAF in response to activating and inactivating mutation 68
Synthesis of phosphatidylserine by base exchange in rat cerebellum and cortex 68
Evaluation of goiter using ultrasound criteria: a survey in a middle schoolchildren population of a mountain area in Central Italy. 68
Acute liver damage following intravenous glucocorticoid treatment for Graves’ ophthalmopathy 68
Turning a Tumor Microenvironment Pitfall into Opportunity: Discovery of Benzamidoxime as PD-L1 Ligand with pH-Dependent Potency 67
Search of RET/PTC rearrangement and BRAF and RAS mutations in a umbrian papillary thyroid carcinoma cohort showed high prevalence of BRAF mutation and allowed to detect a new mutation of BRAF oncoprotein 67
Caratteristiche genetiche di una coorte di carcinomi papillari della tiroide raccolta in Umbria e loro significato clinico 67
Microsomal prostaglandin E2 synthase-1 is induced by conditional expression of RET/PTC in thyroid PCCL3 cells through the activation of the MEK-ERK pathway 67
Lo studio dell’espressione genica indotta da RET/PTC nella linea cellulare PCCL3 evidenzia l’attivazione precoce di geni coinvolti nella regolazione della risposta immunitaria. 66
Intracellular Signal Transduction and Modification of the Tumor Microenvironment Induced by RET/PTCs in Papillary Thyroid Carcinoma 66
Sunitinib inhibits the growth of thyroid tumor xenografts in mice by acting primarily on tumor angiogenesis 64
Clinical prognosis in BRAF-mutated PTC 64
Characterization of a non-clonal intrachromosomal rearrangement between the H4 and the PTEN gene (H4/PTEN) in human thyroid cell lines and papillary thyroid cancer specimens 63
Ventilatory response to exercise in diabetic subjects with autonomic neuropathy 63
Surgical Treatment of sporadic medullary carcinoma: our strategy and outcome of treatment 63
Genetic markers in thyroid neoplasia 63
Sunitinib exerts only limited effects on the proliferation and differentiation of anaplastic thyroid cancer cells 63
Proteomic analysis of papillary thyroid carcinomas reveals demodulation of signal transduction pathways, increased resistance to oxidative stress and gain of invasive phenotype. 62
Iodide transporters NIS and AIT-B mRNA expression in papillary thyroid carcinomas carrying the BRAFV600E mutation 62
Totale 8.546
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.675
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.675
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021903 0 0 0 0 0 115 108 16 191 63 135 275
2021/20221.247 36 215 35 113 31 8 18 397 6 49 139 200
2022/20232.106 179 394 30 193 178 206 2 110 710 21 68 15
2023/2024853 57 106 33 18 20 6 155 28 159 25 123 123
2024/20252.088 24 218 99 98 228 79 49 201 448 132 332 180
2025/20262.136 351 347 233 567 513 125 0 0 0 0 0 0
Totale 11.543